HMNC Brain Health appoints Dr Katarina Jelic Maiboe Head of Regulatory Affairs

pharmafile | November 3, 2021 | Appointment | Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing HMNC Brain Health, appointments 

HMNC Brain Health, a clinical-stage biopharma company pioneering the development of personalised therapies powered by predictive companion diagnostics, today announced the appointment of Dr Katarina Jelic Maiboe as Head of Regulatory Affairs, effective November 1, 2021.

HMNC Brain Health CEO, Benedikt con Braunmühl, said “Dr Maiboe is a proven leader in managing regulatory strategy and provides critical expertise as we progress our clinical pipeline and growth agenda. HMNC is committed to delivering critical mental health treatments through a novel precision psychiatry approach, and we are honoured to welcome her to our growing team.”

Dr Maiboe will play a critical role in driving HMNC’s commercial strategy and achieving key regulatory approvals.

Related Content

Sanofi axes four major players from its executive committee

Sanofi has announced it will cull its executive committee under plans orchestrated by new Chief …


Dr Richard Torbett is named as the new Chief Executive of the ABPI

The Association of the British Pharmaceutical Industry (ABPI) has appointed Dr Richard Torbett as its …


Insys Therapeutics names current CFO Andrew Long as company’s new CEO

Insys Therapeutics has said Andrew Long will take over from Saeed Motahari as the company’s …

Latest content